Literature DB >> 30423051

Using Core-genome Multilocus Sequence Typing to Monitor the Changing Epidemiology of Methicillin-resistant Staphylococcus aureus in a Teaching Hospital.

Yan Chen1,2, Lu Sun1, Dandan Wu3, Haiping Wang1, Shujuan Ji1, Yunsong Yu1.   

Abstract

Background: This study was performed to elucidate the changing epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in a Chinese teaching hospital.
Methods: We performed whole-genome sequencing and phylogenetic analysis on MRSA isolates recovered at Sir Run Run Shaw Hospital (SRRSH) from 2013 to 2015. MRSA isolates underwent susceptibility testing, resistance determinant screening, virulence assays and clinical data analysis.
Results: A total of 292 MRSA infections were identified during the study period. Of these, most belonged to sequence type (ST) 5 (51.4%; 150 of 292) and ST59 (23.3%; 68 of 292). The proportion of ST5 MRSA decreased from 68.3% in 2013 to 32.1% in 2015, and the proportion of ST59 MRSA increased from 8.9% to 41.0%. Core-genome phylogenetic analysis revealed that ST59 MRSA isolates exhibited wider genotypic diversity than ST5 MRSA isolates in both healthcare-onset and community-onset groups. Minimum spanning trees showed that a cluster of ST5 MRSA was circulating at SRRSH, whereas the ST59 MRSA infections were mostly sporadic. ST59 MRSA caused 45.2% of the 93 skin and soft-tissue infection cases and displayed lower levofloxacin (11.8%) and ciprofloxacin (19.1%) resistance rates than the ST239 and ST5 MRSA isolates. ST59 healthcare-onset MRSA displayed enhanced virulence in the skin infection model and hemolysis assays. Notably, these isolates had virulence levels similar to those of classic community-associated MRSA strains. Conclusions: ST59 MRSA strains with high virulence potential have been replacing ST5 MRSA in predominance in SRRSH and causing nosocomial infections. Whole-genome sequencing is a powerful tool to monitor changes in the epidemiology of MRSA in hospitals.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30423051     DOI: 10.1093/cid/ciy644

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

1.  Reduced Ceftaroline Susceptibility among Invasive MRSA Infections in Children: a Clinical and Genomic Investigation.

Authors:  J Chase McNeil; Lauren M Sommer; Jesus G Vallejo; Kristina G Hulten; Sheldon L Kaplan; Anthony R Flores
Journal:  Antimicrob Agents Chemother       Date:  2022-09-27       Impact factor: 5.938

2.  Decreased Incidence of Methicillin-Resistant Staphylococcus aureus Bacteremia in Intensive Care Units: a 10-Year Clinical, Microbiological, and Genotypic Analysis in a Tertiary Hospital.

Authors:  Haein Kim; Eun Sil Kim; Seung Cheol Lee; Eunmi Yang; Hee Sueng Kim; Heungsup Sung; Mi-Na Kim; Jiwon Jung; Min Jae Kim; Sung-Han Kim; Sang-Oh Lee; Sang-Ho Choi; Jun Hee Woo; Yang Soo Kim; Yong Pil Chong
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  A random forest model based on core genome allelic profiles of MRSA for penicillin plus potassium clavulanate susceptibility prediction.

Authors:  Hemu Zhuang; Feiteng Zhu; Peng Lan; Shujuan Ji; Lu Sun; Yiyi Chen; Zhengan Wang; Shengnan Jiang; Linyue Zhang; Yiwei Zhu; Yan Jiang; Yan Chen; Yunsong Yu
Journal:  Microb Genom       Date:  2021-09

4.  Genetic Characteristics of Multiple Copies of Tn1546-Like Elements in ermB-Positive Methicillin-Resistant Staphylococcus aureus From Mainland China.

Authors:  Haiping Wang; Dandan Wu; Lingfang Di; Feiteng Zhu; Zhengan Wang; Lu Sun; Yiyi Chen; Shengnan Jiang; Hemu Zhuang; Mengzhen Chen; Shujuan Ji; Yan Chen
Journal:  Front Microbiol       Date:  2022-02-28       Impact factor: 5.640

5.  Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing.

Authors:  Bingjie Wang; Yanlei Xu; Huilin Zhao; Xinyi Wang; Lulin Rao; Yinjuan Guo; Xie Yi; Longhua Hu; Shuying Chen; Lizhong Han; Junying Zhou; Guoxiu Xiang; Long Hu; Liang Chen; Fangyou Yu
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.